Page last updated: 2024-09-05

lu 135252 and Edema

lu 135252 has been researched along with Edema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bakris, G; Black, H; Krum, H; Linas, S; Lindholm, LH; Linseman, JV; Warren, MS; Weber, MA; Weiss, R; Wiens, BL	1

Trials

1 trial(s) available for lu 135252 and Edema

Article	Year
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet (London, England), 2009, Oct-24, Volume: 374, Issue:9699 Topics: Aged; Analysis of Variance; Blood Pressure Monitoring, Ambulatory; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Edema; Endothelin A Receptor Antagonists; Female; Humans; Hypertension; Male; Middle Aged; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Systole; Treatment Outcome	2009

Article

Year

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.

Lancet (London, England), 2009, Oct-24, Volume: 374, Issue:9699

Topics: Aged; Analysis of Variance; Blood Pressure Monitoring, Ambulatory; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Edema; Endothelin A Receptor Antagonists; Female; Humans; Hypertension; Male; Middle Aged; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Systole; Treatment Outcome

2009